CME/CE Accredited Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Lisa Larkin, MD, FACP, NCMP | Ekta Kapoor, MBBS, FACP, NCMP
Hot flashes and night sweats affect most women during the menopause transition and last for 7 to 10 years, on average. Despite the availability of both hormonal and nonhormonal therapies, most women receive no treatment at all. In this activity, expert faculty will review novel nonhormonal treatments in development as well as a range of available treatment options.
Founder and CEO Ms.Medicine, President and CEO Lisa Larkin MD and Associates, Treasurer Board of Trustees the North American Menopause Society, Cincinnati, OH
Associate Director Mayo Clinic Women’s Health, Associate Professor of Medicine Consultant, Divisions of General Internal Medicine and Endocrinology, Diabetes, Metabolism and Nutrition Mayo Clinic, Rochester, MN
Supported by Astellas
Daniel A. Solomon, MD | Charles Vega, MD, FAAFP
This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.
Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine, Harvard Medical School, Boston, MA
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA
Supported by an educational grant from Genentech, a member of the Roche Group
Pamela Kushner, MD, FAAFP
Discussion on developments in VTE Prophylaxis of Acutely Ill Medical Patients and treatment of DVT/PE
Sponsored by Janssen Pharmaceuticals, Inc.
Cory Rubin, MD, FAAD
Come learn about the burden and management of uncontrolled, moderate-to-severe atopic dermatitis in your appropriate patients and a treatment option that may help them. @2021 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved 03/2021 DER.21.03.0013
Sponsored by Regeneron and Sanofi Genzyme
Erin D. Michos, MD, MHS | John R. Nelson, MD, FACC, FNLA, FASNC
This clinically-focused activity will interactively address many important clinical issues regarding the management of LDL cholesterol and elevated triglycerides with the goal of providing the insight, strategies, and practical guidance to effectively manage patients at high ASCVD risk. The expert faculty will compare clinical trial data on safety, tolerability, and different effects on lipid-lowering and cardio-protective benefits of the various treatment strategies available.
Associate Professor of Medicine and Epidemiology, Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD
Director, California Cardiovascular Institute, CA-ACC-Governmental Relations Committee Member, Fresno, CA
Supported by Amarin Pharma Inc.
Diego J. Maselli, MD, FCCP
Early and accurate diagnosis of chronic obstructive pulmonary disease (COPD) followed by optimal management are very important. This educational activity, will discuss the diagnosis of COPD, goals for treatment, pharmacological management, and the role of inhaled therapy and inhaler choice in the management of patients with COPD.
Associate Professor of Medicine, Division of Pulmonary Diseases & Critical Care, University of Texas Health at San Antonio, Director, Respiratory Care, University Health System, Director, Severe Asthma Program, University Health System
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Peter P. Toth, MD, PhD, FCCP, FASCP, FAHA, FACC
This program will review recent developments in the treatment of patients with chronic heart failure and discuss the important role of the primary care physician.
Director of Preventative Cardiology, CGH Medical Center, Sterling, Illinois, , Professor of Clinical Family and Community Medicine, University of Illinois College of Medicine, Peoria, Illinois, , Professor of Clinical Medicine, Michigan State University College of Osteopathic Medicine, East Lansing, Michigan, , Adjunct Associate Professor Medicine, Johns Hopkins University School of Medicine
Sponsored by Novartis Pharmaceuticals Corporation
Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP
The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain versus the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse to manage patients’ pain and medication use optimally.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY
Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Supported by Opioid Analgesic REMS Program Companies
Javeed Siddiqui, MD,MPH
Sponsored by Merck
Tina K. Thethi, MD, MPH, FACE
Type 2 diabetes mellitus (T2DM) is a multi-factorial disease, and its prevalence continues to rise. Lifestyle changes remain a key component of the interventions that require patient participation to initiate and sustain. Additionally, several pharmacological options are available to address the various pathophysiological factors involved in T2DM. Some of these agents have demonstrated cardiovascular benefit, and the renoprotective effect of certain medications has also been investigated with promising results. This knowledge helps PCPs to use appropriate pharmacological agents to individualize treatment plans while following the principles of patient centered care.
Associate Investigator, AdventHealth, Translational Research Institute, Endocrinologist, AdventHealth, Diabetes Institute, Orlando, FL
Peng Thim Fan, MD, FACP | Jeffrey Rado, MD, MPH, FAPA | Karol E. Watson, MD, PhD
What do primary care providers need to know about hypertension, anxiety, and fibromyalgia? Join cardiologist Karol Watson, psychiatrist Jeffrey Rado, and rheumatologist Peng Thim Fan as they review important questions, they get asked about these topics!
Clinical Professor of Medicine, Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA
Associate Professor, Northwestern University, Feinberg School of Medicine, Chicago, IL
Professor of Medicine/Cardiology, David Geffen School of Medicine at UCLA, Co-director, UCLA Program in Preventive Cardiology, David Geffen School of Medicine at UCLA, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA, Los Angeles, CA
Rogelio Silva, MD
Discuss the diagnosis of Exocrine Pancreatic Insufficiency (EPI) and the treatment with CREON.
Sponsored by AbbVie
John E. Anderson, MD
Evaluate when the guidelines recommend GLP-1 RA use for T2D treatment. Review the glucose-dependent mechanism of action, safety, and dosing of a once-weekly GLP-1 RA. Discuss the efficacy and safety data from pivotal T2D glycemic control trials and from the cardiovascular outcomes trial.
The Frist Clinic, Nashville, TN
Sponsored by Novo Nordisk Inc.
Philip Schoenfeld, MD, MSEd, MSc
This activity will provide an evidence-based approach to the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by Allergan and Ironwood Pharmaceuticals, Inc. Salix Pharmaceuticals
Peter Chen, MD | Chad R. Worz, PharmD, BCGP, FASCP
Neutralizing monoclonal antibodies (mAbs) first received emergency use authorization (EUA) in November 2020 for treating at-risk patients with COVID-19--and the field has continued to evolve ever since. This presentation provides an update in the latest evidence showing reduced severe illness and hospitalization in patients treated with neutralizing mAbs. The expert presenters will explain the science and practical issues of using mAbs to treat patients with COVID-19 in outpatient and skilled nursing facility settings while also answering your questions from their multidisciplinary perspectives.
Professor of Medicine and Biomedical Sciences, Director, Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA,
Chief Executive, The American Society of Consultant Pharmacists, Alexandria, VA,
Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Ted Okerson, MD
Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.
Sponsored by AstraZeneca Pharmaceuticals, LP
Rajeev Raghavan, MD | Melanie Hoenig, MD
Kidney and electrolyte problems affect nearly 15% of the U.S. adult population. Yet, many health care providers are intimidated by patients with these complex issues. Through the structure of five fictional patient cases, expert faculty will give HCPs the tools that they need to care for patients with acute kidney injury and chronic kidney disease while utilizing current best practices. This session will also explore patient-centered treatments for some common electrolyte abnormalities.
Associate Professor of Medicine, Baylor College of Medicine, Houston, TX
Associate Professor, Harvard Medical School, Boston, MA
Katherine Carroll, MD
Neurology Pearls will provide the primary care clinician with the most up-to-date knowledge needed to identify and treat commonly seen neurological outpatient diagnoses, including headache, dizziness, peripheral neuropathy, tremor, and seizure vs. syncope.
Assistant Professor of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL
Matthew Mintz, MD, FACP
This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.
Associate Clinical Professor of Medicine at George Washington University School of Medicine & Health Sciences, Internal Medicine and Primary Care Physician, Private Practice in Bethesda, Maryland
Sponsored by GlaxoSmithKline